A New Development in Medicine: Tear Biomarkers and Non-invasive Disease Testing
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 199
Special Issue Editors
Interests: biomarkers and diagnosis; proteomics and artificial intelligence; cell signaling; drug discovery
Special Issue Information
Dear Colleagues,
In the realm of modern medicine, we stand at the threshold of an exciting era, one where the unassuming tear fluid harbors remarkable potential as a wellspring of biomarkers. This potential extends far beyond ophthalmology, encompassing a spectrum of diseases, ranging from neurological conditions to diabetes to cancer and mental health disorders. Tear biomarkers, characterized by their non-invasive nature and ease of collection, offer a transformative approach to early disease detection and monitoring.
As we embark on this journey of exploration, we recognize the profound implications this research area holds for the medical field. Tear biomarkers may soon transcend novelty to become an integral facet of routine medical care, redefining how we diagnose and treat diseases.
In light of this, we extend an invitation to contribute your research papers and expert reviews to this Special Issue. We eagerly anticipate submissions that illuminate the current state of the art in this promising domain, particularly those that address the following key inquiries:
(1) Which tear biomarkers exhibit the most promise in early disease diagnosis?
(2) How can tear biomarkers be harnessed for proactive disease screening among at-risk populations?
(3) In what ways can tear biomarkers facilitate ongoing disease progression monitoring and treatment efficacy assessments?
(4) How might tear biomarkers drive the development of novel diagnostic tests and therapeutic interventions?
Your valuable insights and contributions are pivotal as we navigate this exciting development. We eagerly await your submissions.
Dr. Kunhong Xiao
Dr. Leanne Labriola
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tear biomarker
- tear film
- tear fluid
- tear testing
- diagnosis
- early disease diagnosis
- companion diagnostics
- disease screening
- disease progression monitoring
- in vitro diagnostics (IVD)
- point-of-care testing (POCT)
